"Naloxone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors.
| Descriptor ID |
D009270
|
| MeSH Number(s) |
D03.132.577.249.706 D03.605.497.750 D03.633.400.686.750 D04.615.723.795.706
|
| Concept/Terms |
MRZ-2593- MRZ-2593
- MRZ 2593
- MRZ2593
- MRZ 2593-Br
- MRZ 2593 Br
- MRZ 2593Br
|
Below are MeSH descriptors whose meaning is more general than "Naloxone".
Below are MeSH descriptors whose meaning is more specific than "Naloxone".
This graph shows the total number of publications written about "Naloxone" by people in this website by year, and whether "Naloxone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1999 | 2 | 1 | 3 |
| 2002 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2007 | 0 | 2 | 2 |
| 2009 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 1 | 1 | 2 |
| 2017 | 0 | 2 | 2 |
| 2018 | 0 | 1 | 1 |
| 2019 | 3 | 1 | 4 |
| 2020 | 1 | 2 | 3 |
| 2021 | 1 | 2 | 3 |
| 2022 | 0 | 5 | 5 |
| 2023 | 0 | 4 | 4 |
| 2024 | 3 | 2 | 5 |
| 2025 | 0 | 2 | 2 |
| 2026 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Naloxone" by people in Profiles.
-
Correlates of Rural Naloxone Possession Among People Who Use Drugs: A Multi-State Cross-Sectional Analysis. J Rural Health. 2026 Jun; 42(3):e70187.
-
Evaluation of an Opioid Use Disorder Consult Service on Success of Non-Home Discharge Recommendations. Subst Use Addctn J. 2026 Jul; 47(3):834-841.
-
Public Support for Harm Reduction Strategies to Address the Opioid Pandemic in the United States: A Latent Class Analysis. Subst Use Misuse. 2026; 61(10):1719-1727.
-
Differences by race and ethnicity in drug use patterns, harm reduction practices and barriers to treatment among people who use drugs in Rhode Island. Harm Reduct J. 2025 03 20; 22(1):38.
-
The CARE Overdose Response Team in Chicago: A Multidisciplinary Out-of-Hospital Post-Opioid Overdose Intervention. Prehosp Emerg Care. 2025; 29(4):534-539.
-
Agent-Based Model of Combined Community- and Jail-Based Take-Home Naloxone Distribution. JAMA Netw Open. 2024 12 02; 7(12):e2448732.
-
Strategies used to reduce harms associated with fentanyl exposure among rural people who use drugs: multi-site qualitative findings from the rural opioid initiative. Harm Reduct J. 2024 08 24; 21(1):154.
-
Accessibility of Naloxone in Pharmacies Registered Under the Illinois Standing Order. West J Emerg Med. 2024 Jul; 25(4):457-464.
-
Community-Based Cluster-Randomized Trial to Reduce Opioid Overdose Deaths. N Engl J Med. 2024 09 19; 391(11):989-1001.
-
Implementation of perinatal quality collaborative statewide initiative improves obstetrical opioid use disorder care and outcomes. Am J Obstet Gynecol. 2025 01; 232(1):130.e1-130.e10.